?

Brookwell Limited

Portfolio analysis at 31 December 2012

Details of the investments held in the D Share portfolio at 31 December 2012 are set out below.

Investee company

Number of

Current

Current

Percentage


shares held

value per

value

of portfolio



share





pence

£'000


Northern Investors Company

791,283

293.00

2,319

67.3%

Universe Group

9,150,000

3.50

320

9.3%

Metalrax Group

6,835,040

4.25

291

8.4%

Private & Commercial Finance Group

4,696,200

5.75

270

7.8%

Squarestone Brasil 1

700,000

23.87

167

4.8%

Evocutis

9,779,860

0.70

69

2.0%

Hotel Corporation

722,071

1.30

9

0.3%

Union Medtech

156,250

1.25

2

0.1%

ESV Group

20,000

2.00

0

0.0%

Orchid Developments 1

6,565,447

-

-

0.0%

Total portfolio investments



3,447

100.0%

Other net assets



469


Net assets



3,916


Notes

1              These investments are suspended/delisted.

2              The above table excludes the Company's holdings in Trans Balkan Investments and in warrants issued by Squarestone Brasil, both of which are delisted and carried at nil.

For further information please contact:

Brookwell Limited

Tom Lancaster-King Tel: 01481 726 034

Progressive AIM Realisation Limited (Investment manager)

Robert Legget Tel: 020 7566 5550

Deloitte Corporate Finance (Nominated adviser)

James Lewis / Paul Zimmerman Tel: 020 7936 3000

Marshall Securities Limited (Broker)

John Webb Tel: 020 7490 3788

9 January 2013

Website: www.brookwelllimited.com


This information is provided by RNS
The company news service from the London Stock Exchange
ENDMSCQKLFBXFFEBBB
distributed by